Axcella Stock Financials


USD 1.93  0.09  4.89%   

We suggest to use analysis of Axcella Health fundamentals to see if markets are presently mispricing the company. We were able to break down and interpolate thirty available fundamental indicators for Axcella Health, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Axcella Health financials, including its shares outstanding, ebitda, current ratio, as well as the relationship between the number of shares shorted and cash per share . Please also double-check Axcella Health price to earning to validate the company can sustain itself down the road. Use Axcella Health to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Axcella Health to be traded at $2.41 in 90 days.
With this module, you can analyze Axcella financials for your investing period. You should be able to track the changes in Axcella Health individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Axcella Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Axcella Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Axcella Health's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 97
Axcella Health has more than 97 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Axcella Health stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Axcella Health's official financial statements usually reflect Axcella Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Axcella Health. For example, before you start analyzing numbers published by Axcella accountants, it's critical to develop an understanding of what Axcella Health's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Axcella Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Axcella Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Axcella Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Axcella Health. Please utilize our Beneish M Score to check the likelihood of Axcella Health's management to manipulate its earnings.

Axcella Health Company Summary

Axcella Health competes with Svenska Kullager, Kennametal, Lincoln Elec, Samsonite Intl, and 361 Degrees. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address840 Memorial Drive
Phone857 320 2200
CurrencyUSD - US Dollar
You should never invest in Axcella Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Axcella Stock, because this is throwing your money away. Analyzing the key information contained in Axcella Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Axcella Health Key Financial Ratios

Generally speaking, Axcella Health's financial ratios allow both analysts and investors to convert raw data from Axcella Health's financial statements into concise, actionable information that can be used to evaluate the performance of Axcella Health over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Axcella Health reports annually and quarterly.

Axcella Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Axcella Health's current stock value. Our valuation model uses many indicators to compare Axcella Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axcella Health competition to find correlations between indicators driving Axcella Health's intrinsic value. More Info.
Axcella Health is number one stock in total asset category among related companies. It is the top company in total debt category among related companies making up about  0.44  of Total Debt per Total Asset. The ratio of Total Asset to Total Debt for Axcella Health is roughly  2.26 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Axcella Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Axcella Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axcella Health's earnings, one of the primary drivers of an investment's value.

Axcella Health Systematic Risk

Axcella Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Axcella Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Axcella Health correlated with the market. If Beta is less than 0 Axcella Health generally moves in the opposite direction as compared to the market. If Axcella Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Axcella Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Axcella Health is generally in the same direction as the market. If Beta > 1 Axcella Health moves generally in the same direction as, but more than the movement of the benchmark.

About Axcella Health Financials

What exactly are Axcella Health Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Axcella Health's income statement, its balance sheet, and the statement of cash flows. Potential Axcella Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Axcella Health investors may use each financial statement separately, they are all related. The changes in Axcella Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axcella Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Axcella Health is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Axcella has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Axcella Health October 6, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Axcella Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Axcella Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Axcella Health based on widely used predictive technical indicators. In general, we focus on analyzing Axcella Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Axcella Health's daily price indicators and compare them against related drivers.
Downside Deviation6.26
Information Ratio0.0178
Maximum Drawdown42.02
Value At Risk(11.17)
Potential Upside12.87
Please continue to Trending Equities. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEO Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.